Parvovirus B19 VP2 protein-VLP

Produktnummer ABIN7489949

Dieses VLP Parvovirus B19 VP2-Protein wird in Escherichia coli (E. coli) exprimiert.

Kurzübersicht für Parvovirus B19 VP2 protein-VLP (ABIN7489949)

Target: Parvovirus B19 VP2

Protein-Typ: VLP

Spezies: Human Parvovirus B19 (HPV B19)

Quelle: Escherichia coli (E. coli)

Applikation: Immunoassay (IA)

Produktdetails

Spezifität: Parvovirus B19 VP2 Antigen

Produktmerkmale: E. coli derived recombinant protein

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

The VLPs are produced in SF9 insect cells (Baculovirus), purified by chromatography and suitable for the sensitive and specific detection of IgG and IgM antibodies against Parvovirus B19. The other seven recombinant Parvovirus B19 antigens (NS1, VP1, VP2, Pep A-D) are produced in E.coli and purified by chromatography in the presence of urea. Purity of ≥ 95% is confirmed via SDS-PAGE (Coomassie staining) for all recombinant antigens.,Parvovirus B19, recombinant VP2 (full length, linear epitopes, VP1 aa 233-781). Molecular mass: 63 kDa.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: 50 mM Tris/HCl pH 8.0, 500 mM NaCl and 8 M urea

Lagerung: -80 °C

Antigendetails

Target: Parvovirus B19 VP2

Hintergrund: Parvovirus B19 was the first known human virus in the Parvoviridae family. During childhood it causes the ""childhood rash"" also called ""fifth disease"" or erythema infectiosum, but the virus can also affect adults.

Molekulargewicht: 63 kDa